(Journal Article): Prevalence of Type 2 Diabetic Patients Within the Targets of Care Guidelines in Daily Clinical Practice: A Multi-Center Study in Brazil
 
Gomes MB, Gianella D, Faria M, Tambascia M, Fonseca RM, Rea R, Macedo G, Filho JM, Schmid H, Bittencourt AV, Cavalcanti S, Rassi N, Pedrosa H, Dib SA (Department of Medicine, Unit of Diabetes, State University Hospital of Rio de Janeiro, Brazil, mariliabgomes@uol.com.br )
 
IN: Rev Diabet Stud 2006; 3(2):82-87

Fulltext:    HTML  PDF

ABSTRACT: Major clinical studies have shown that the targets for blood glucose, lipid profile and blood pressure in type 2 diabetic patients are difficult to maintain in clinical practice. However, there are few data concerning South American populations. Using guidelines represented by the Brazilian Diabetes Society, we evaluated cardiovascular (CV) risk factors, glycemic control and the availability of screening for diabetes complications in 2233 (60% females) outpatients with type 2 diabetes aged 59.2 ± 11.3 yr and with a known duration of diabetes of 9.2 ± 7.2 yr, collected from 8 Brazilian cities. The outcome showed that less intensive clinical care available for diabetic patients in Brazil compared to western industrialized countries leads to widespread poor metabolic control and health status. Less than 30% of the patients reached the target for systolic (28.5%, < 130 mmHg) and diastolic (19.3%, < 80 mmHg) blood pressure, BMI (24.6%, < 25 kg/m2), LDL cholesterol (20.6%, < 2.6 mmol/l) and only 46% reached the goal for HbA1c (one % point above the upper limits of normality for the method used). Only 0.2% of patients reached all the targets. A lower number of women reached the targets for HbA1c, LDL and HDL cholesterol than men (p < 0.001). Women were less likely than men to have funduscopy examinations and urine albumin testing (p < 0.001). We conclude that the national goals for glycemic control, blood pressure and lipid levels are rarely achieved in clinical practice, and that the availability for diabetic complication screening is low. The quality of diabetes care, in particular for women, is poor and should be further reviewed in developing countries.

TYPE OF PUBLICATION: Original article

REFERENCES:

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalences of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004. 27:1047-1053.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000. 321:405-412.
3. Grundy SM, Cleeman JL, Bairey Merz CN, Brewer HB, Clark LT, Hunninghake DB. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004. 110:227-239.
4. Kemp TM, Barr EL, Zimmet PZ, Cameron AJ, Welborn TA, Colagiuri S, Phillips P, Shaw JE. Glucose, lipid, and blood pressure control in Australian adults with type diabetes. The 1999-2000 AusDiab. Diabetes Care 2005. 28:1490-1492.
5. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004. 291:335-342.
6. McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Von Gizycki H, Sowers JR. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002. 25:718-723.
7. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers. University Health System Consortium (UHC), Diabetes Benchmarking Project Team. Diabetes Care 2005. 28:337-344.
8. Miller CD, Phillips LS, Tate MK, Porwoll JM, Rossman SD, Cronmiller N, Gebhart SS. Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care 2000. 23:444-448.
9. Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S. The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996-2003. Steering Committee of the Swedish National Diabetes Register. Diabet Med 2005. 22:1420-1426.
10. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care 1992. 15:1509-1516.
11. Sociedade Brasileira de Diabetes. Consenso Brasileiro sobre Diabetes - November 2002. Available from http://www.diabetes.org.br/consenso. Accessed October 2003.
12. Instituto Brasileiro de Geografia e Estatística. Censo de 2004. Available from http://www.ibge.gov.br/estatistica/pesquisas. Accessed December 2004.
13. Kennedy AG, MacLean CD, Littenberg B, Ades PA, Pinckney RG. The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care 2005. 28:1029-1033.
14. Gagliardino JJ, Etchegoyen G. A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 2001. 24:1001-1007.
15. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005. 28:514-520.
16. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998. 28:1258-1265.
17. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality, The San Antonio Heart Study. Diabetes Care 1998. 21:1167-1172.
18. Edwards R, Burns JA, McElduff P, Young RJ, New JP. Variations and outcomes of diabetes care by socio-economic status in Salford, UK. Diabetologia 2003. 46:750-759.
19. Hippisley-Cox J, O'Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population-based survey of 53,000 patients in primary care. BMJ 2004. 329:1267-1269.